Stephens Reaffirms "Overweight" Rating for CareDx (NASDAQ:CD

Stephens reaffirmed their overweight rating on shares of CareDx (NASDAQ:CDNA – Free Report) in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has a $15.00 target price on the stock. CareDx Stock Up 3.0 % Shares of CDNA stock opened at $8.31 on Wednesday. The firm has a market cap of $430.29 […]

Related Keywords

United States , , Investment Management , Bellevue Group , Caredx Inc , Blackrock Inc , Kent Lake Capital , Free Report , Get Free Report , Lake Capital , Street Corp , Allosure Kidney , Allomap Heart , Allosure Heart , Allosure Lung , Caredx Daily , Caredx , Nasdaq Cdna , Ecdna , Medical , Reiterated Rating , Stephens ,